Skip to main content
. 2022 Dec 14;10(1):ofac674. doi: 10.1093/ofid/ofac674

Table 1.

Serologic Testing for SARS-CoV-2

Potential Value for Serologic Testing
Assessing potential sequelae of prior infection Delayed onset cytokine release syndrome
PASC (“long COVID”)
MIS-C, MIS-A
Qualifying convalescent plasma
Serologic Testing Not Indicated
Assessing need for COVID-19 vaccination
Testing of T-cell responses
Indications Where Data Are Evolving
Determining organ transplant candidacy
Prioritizing limited monoclonal antibody to patients most likely to benefit]

Abbreviations: COVID, coronavirus disease 2019; MIS-A, multisystem inflammatory syndrome in adults; MIS-C, MIS in children; PASC, postacute sequelae of severe acute respiratory syndrome coronavirus 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.